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Biology and medicine changed forever in June 2000 when the first complete draft sequence 
of human genome was announced. This was quickly followed by expansion of bioinformatic 
data management possibilities due to remarkable increase in computing capacity. In recent 
years, RNA-sequencing (RNA-seq) has become superior choice in revealing the   
transcriptome of a cell and when studying global gene expression profiling. It offers better 
sensitivity, range of expression, more sequencing depth and allows to sequence novel 
genomes with low background noise signal compared to other existing conventional array 
technologies.  
 
The aim of this thesis was to analyse RNA-sequencing data of untreated and treated samples 
of two melanoma cancer cell lines. This thesis is part of the research conducted at the 
laboratory of Professor Päivi Ojala, Translational Cancer Biology Research Program Unit, 
Faculty of Medicine, University of Helsinki. Laboratory’s research goal is to find and produce 
novel knowledge and deepen the current understanding of the mechanisms of metastasis in 
melanoma cancer. 
 
The melanoma cancer cell lines WM852 and Bowes were co-cultured according to 
experimental setup together with lymphatic endothelial cells. After culturing two cell types were 
separated with a method utilizing magnetic nanoparticles, and the RNA was extracted from 
the cancer cell samples. The RNAs were sent to DNA Sequencing and Genomics laboratory 
of Institute of Biotechnology to be sequenced. The sequencing results were then quality 
tested, aligned to a human reference genome GRCh38.76, and aligned reads were counted 
for the differential expression analysis. Generally Applicable Gene-set Enrichment analysis 
(GAGE) and Pathway analysis were done to get an impression of the functional and 
mechanistic changes of the treatment.  
 
The interesting gene expression changes found by this experiment are currently being 
validated using qRT-PCR. These results will contribute towards expanding the understanding 
of malignant melanoma and metastasis, further help us to develop better treatments for cancer 
centric diseases. 
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Biologian ja biolääketieteellinen tutkimus muuttuivat vuonna 2000 ratkaisevasti, kun 
ensimmäinen kokonainen vedos ihmisen genomista julkaistiin kaikkien saataville. 
Bioinformaattisen tietojen käsittelyn mahdollisuudet lisääntyivät samanaikaisesti valtavasti 
voimakkaan tietokoneiden laskentakapasiteetin kasvun seurauksena. RNA-sekvenssoinnin 
suorittamine on viime vuosina yleistynyt, halutessa selvittää solun transkriptomin sisältö. Se 
tarjoaa suuremman herkkyyden ja  pienemmän taustamelusignaalin ja mittaa tehokaammin 
geeni-ilmentymisen absoluuttista määrää kuin tähän asti muilla menetelmillä on saavutettu. 
RNA-sekvenssointi on myös sekvensoimattoman genomin tai mutatoituneet syövän 
selvittämiseksi paras saatavissa oleva vaihtoehto.  
 
Tämän tutkimuksen tavoitteena on selvittää imusuonten seinämäsolujen interaktion 
vaikutusta melanoomasolujen geeniekspressioon. Tämä tehtiin vertaamalla kahden 
erityyppisen melanooma ihosyöpäsolulinjan geenien ekspressioita ennen ja jälkeen käsittelyn. 
Syöpäsolujen RNA-sekvenssoinnin ja tulosten analysoinnin kautta voidaan ymmärtää 
paremmin melanoomaa ja metastasoimiseen liittyviä biologisia mekanismeja. Tutkimus 
toteutettiin professori Päivi Ojalan tutkimusryhmässä, joka on osa Helsingin yliopiston 
lääketieteellisen tiedekunnan Translationaalisen syöpäbiologian tutkimusohjelmaa..  
 
Melanooma WM852- sekä Bowes-syöpäsolulinjat kasvatettiin koesuunnitelman mukaisessa 
yhteiskasvatusmallissa yhdessä imusuonten seinämäsolujen (LEC) kanssa, jonka jälkeen 
solut erotettiin toisistaan ja syöpäsolujen RNAt eristettiin. Sekvenssoiti toteutetiin ”DNA 
Sequencing and Genomics” laboratoriossa Biotekniikan Instituutissa. Sekvenssointituloksien 
laatu tarkastettiin ja rinnastettiin ihmisen referenssigenomia GRCh38.76 vasten, jonka jälkeen 
genomiin rinnastetut sekvenssifragmentit laskettiin. Fragmenttiluvuista suoritettiin 
differentiaalinen ekspressioanalyysi, jonka tuloksena pääteltiin, kuinka paljon geenien 
ilmentyminen on  muuttunut käsittelyn aikana. Geenien ekspressiomuutosten kokonaiskuvan 
saamiseksi suoritettiin lisäksi geenien rikastumis- sekä signalointireittianalyysit.  
 
Tällä hetkellä mielenkiintoisimpia geenilöydöksiä ollaan validoimassa käyttämällä qRT-PCR 
menetelmää sekä funktionaalisia kokeita soluilla. Nämä tulokset lisäävät ymmärrystämme 
melanoomasta ja sen leviämisestä, sekä auttavat kehittämään uusia hoitomuotoja 
syöpätaudeille. 
Avainsanat RNA-sekvenssointi, syöpä, melanooma, metastasia, 
bioinformatiikka 
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Abbreviations 
 
cDNA  copy deoxyribonucleic acid 
DNA   Deoxyribonucleic acid 
dsDNA  double stranded DNA 
ER   Endoplasmic reticulum 
ES  Enrichment scores 
FDR  False discovery rate 
GAGE  Generally applicable gene-set enrichment analysis 
GLM  Generalized linear model 
GO  Gene Ontology 
HTS  High-throughput sequencing 
HUGO  Human Gene Nomenclature Committee 
KEGG  Kyoto encyclopaedia of genes and genomes  
LEC  lymphatic endothelial cell 
LFC   Logarithmic fold change 
MAPK  mitose activated protein kinase  
mRNA  messenger RNA 
miRNA  micro RNA  
RLOG  regularized logarithmic transformation 
  
 
RNA   Ribonucleic acid 
RNA-seq  RNA-sequencing  
rRNA  ribosomal RNA 
siRNA  silencing RNA 
tRNA  transfer RNA 
VEGF  vascular endothelial growth factor  
VST  Variance-stabilizing transformation 
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1 Introduction 
 
This thesis was done for the laboratory of Prof. Päivi Ojala, Translational Cancer Biology 
Program, Research Programs Unit, Faculty of Medicine, University of Helsinki. The aim 
of this thesis was to analyse RNA-sequencing data with the current bioinformatic 
methods. Main methods for this study were differential gene expression analysis, 
generally applicable gene enrichment analysis and pathway analysis. The cells that were 
RNA-sequenced were produced in a cell culturing experiment where the goal was to 
study lymphatic endothelial cell and melanoma cell interaction.  
 
Melanoma refers to a condition in melanocytes when the cells begin to proliferate 
abnormally. Melanocytes localize to the skin, between the epidermis and the dermis, 
where they produce and store melanin pigments. Melanoma is clinically described to 
appear as pigmented macules, which can change in symmetry, size or colour and appear 
as new lesions or in pre-existing lesions (Muller, 2008). Melanoma pathogenesis is 
driven by both genetic and environmental risk factors. The melanoma incidence is 
influenced by skin pigmentation, sun-exposure history as well as extensive UVB/A 
radiation and geographical location (Chin, 2003).  
 
Although melanoma is responsible for the majority of deaths in skin related malignancies, 
it only accounts for about 5 % of all skin cancers (Kim, et al., 2015). Most of the 
diagnosed melanoma that ends up fatal are caused by metastasised nodes which have 
spread around the body (Ferlay, et al., 2014). Therefore, it is important to understand 
the mechanisms of the melanoma metastatic spread to develop better treatments for 
these patients and for this reason, the research done to understand the metastasis 
progression is exceptionally rewarding.  
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THEORETICAL PART 
 
2 Features of genes and gene expression 
 
2.1 Introduction to genetics 
 
The mechanisms that make simple and advanced life possible rely on the structure of 
the double-stranded DNA molecule. DNA is made from simple subunits called 
nucleotides, each consisting of sugar-phosphate molecule with a nitrogen side group, 
base, attached to it. The deoxynucleotides in DNA are adenine, guanine, cytosine and 
thymine, labelled A, G, C and T. According to strict rule defined by the complementary 
structures of the bases A binds to T and C binds to G. DNA cannot form by itself, it has 
to be synthesised from a pre-existing strand. DNA replication occurs with different 
controls and helper auxiliary molecules that affect within the process by allowing it to 
continue with different rates or by inhibiting it completely. The fundamentals of the DNA 
are universal: DNA is the information store for heredity and it’s the way how life is copied 
throughout the living world (Alberts, et al., 2015). 
 
To transmit its information out, DNA must do more than replicate itself. It must express 
its information by guiding the synthesis of other molecules in the cell. Expression 
mechanism is nearly identical in all living organisms and leads to formation of two key 
classes of polymers: RNA and proteins. The first phase of the process is called 
transcription, where DNA sequence is used as a template for the synthesis of RNA 
molecules. Many of the  RNA molecules are directing the synthesis of proteins in an 
process called translation. RNA molecule is formed from a different sugar, ribose, instead 
of deoxyribose and has a different base uracil (U) in place of thymine (T). Newly 
produced transcripts function most notably as messenger RNA (mRNA) molecules which 
guide the synthesis of proteins according to the genetic instructions stored in the DNA. 
Therefore, knowing how to read the mRNA molecules, it is possible to gain major insights 
how individual or groups of cells work. Three sequential nucleobases form a codon which 
tells the cell to produce a specific amino acid, the building block of proteins. In 
transcription, the DNA monomers are written as RNA monomers which are mass 
produced and disposable, whereas DNA in the cell is left intact and untouched. New 
proteins are synthetized from mRNA by using it as a template in an event called 
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translation. Ribosome proteins carry out instructions written in the mRNA by adding 
amino acids together and forming polypeptide chains (Alberts, et al., 2015).  
 
2.2 Genes and chromosomes 
 
In their cells, humans have 46 chromosomes, made up of 23 pairs, which are constructed 
from the DNA. These include 44 chromosomes called autosomes; they are numbered 
from 1 to 22 according to size from the smallest to the largest, as well as the two sex 
chromosomes: X and Y. Each chromosome consist of two very long thin strands of DNA 
chains twisted into the shape of a double helix and are located in the nucleus (the ‘control 
centre’) of the cells.  Since the chromosomes in the nucleus come in 23 pairs, the genes 
that are located as part of the DNA in chromosomes, also appear as pairs. It is 
approximated that only 1% of total genome is made up of genes. These areas are called 
coding DNA regions whereas the areas between genes are called a non-coding DNA. 
Although it is called non-coding DNA it has a very important role to play in regulating 
genes for example switching them on and off.  Alleles are forms of the same gene with 
small differences in their sequence of DNA nucleobases. These small differences in the 
DNA contribute to each unique physical feature phenotype in animalia. In total, human 
genome contains approximately over 20 000 genes.  Some of the genes are also located 
at the mitochondria, which are scattered in cytoplasm (Alberts, et al., 2015). 
 
2.3 Regulation of gene expression 
 
A cell normally expresses only a fraction of its genes, and differentiation and 
development of a cell to multicellular organism is the inevitable outcome of this 
behaviour. Different and specialized cells in multicellular organisms are able to alter the 
pattern of gene expression in response to extracellular signals. Specialized cells express 
different gene profiles at different times. For example, if liver cell is exposed to a hormone 
called glucocorticoid, the production of number of proteins that increases energy 
production from amino acids increases exponentially. When the glucocorticoid is not 
present the protein production returns to its basal unstimulated levels in liver cells. If 
exposed to fat cells, glucocorticoid reduces the production of tyrosine aminotransferase, 
whereas some cell types do not respond to hormone at all (Alberts, et al., 2015). Thus, 
different specialized cell types regularly respond very differently to the same extracellular 
cues. Due to nature of general biological variance in gene expressions, not always the 
same signal causes the same outcome.  Consequently, every cell has its genetically 
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inherited expression level which is not normally subjected to major changes, therefore 
giving each specialized cell type its distinguished characteristics (Alberts, et al., 2015).  
 
 
Regulation of gene expression can take place in at many different stages from DNA to 
RNA to protein (Figure 1). The cell can control the proteins it produces by (1) 
transcriptional control by controlling how often and when the gene is transcribed, (2) RNA 
processing control by controlling the processing and splicing of the RNA transcripts, (3) 
RNA transport and localization control by selecting the cytoplasma localization of mRNAs 
to be exported from the nucleus to the cytoplasma for translation, (4) translational control 
by selecting which mRNA is translated by ribosomes, (5) mRNA degradation control by 
degrading the unnecessary mRNA molecules in the cytoplasm, and (6) protein activity 
control by activating, inactivating, relocalizing or degrading certain proteins. 
 
 
Figure 1. Steps of eukaryotic gene expression control (Alberts, et al., 2015). 
 
Although every regulatory step can and will participate in expressing a gene, 
transcriptional control is the most important point of regulation. Transcriptional control 
switches the process of transcription on and off for individual genes in cells. Every 
eukaryotic gene is typically controlled by many different transcriptional regulators. Some 
of the regulators, also called transcription factors, are bind in the close proximity of the 
gene start site and are intimately linked to the expression of the gene. Some regulators 
or promoter areas which initiates the gene transcription might be far away from the target 
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transcriptional start location and they activate through different regulators. The major 
reason why changes in gene expression might difficult to track is because of the vast 
complexity of the regulatory network inside and outside of the cell.  
 
 
3 Origin of cancer  
 
3.1 Carcinogenesis 
 
Cancer cells are notorious by for two intrinsic properties: they reproduce in defiance of 
the natural limitations on cell growth and division, and they invade and colonize areas 
normally reserved for other cells. It is the combination of these two properties that makes 
the cancers generally dangerous for living organisms. A cell that grows abnormally in 
mass and proliferates uncontrollably will result in a neoplasm, or a tumour. Neoplasm is 
called benign if the tumour cells have not yet become invasive. Benign tumour is usually 
easy to cure by removing the tumour mass from the tissue. If tumour acquires an ability 
to invade into the surrounding tissues, it is considered malignant in other words 
cancerous. Increased invasiveness might allow the cancer cells to enter surrounding 
tissues and form secondary tumours called metastases. In general, the more dispersed 
cancer the harder it is to cure and usually the metastases are the reason for the death 
of the cancer patient (Alberts, et al., 2015). 
 
Cancer is caused by mutations that occur mainly in somatic cells and therefore most 
cancers are not inheritable. Cancer development requires generally multiple mutations 
in growth regulatory genes. Additional drivers of cancer formation are epigenetic 
changes which modify the chromatin structure of the cell without alterating the DNA 
sequence. Factors that play a role in changing the genetic material and in the 
development of cancer are called carcinogens. The factors that change the DNA 
sequence are called mutagens. Different kinds of chemical and physical factors and 
some viruses induce mutations and cancer. Local changes in the nucleotide sequence 
are typically caused by chemical carcinogens like asbestos, tobacco smoke, dioxins or 
natural aflatoxin B1. Radiation, such as x-rays or ultraviolet light, causes typically DNA 
base alterations, double strand breaks and sometimes chromosome breaks and 
chromosomal translocations, where parts of nonhomologous chromosomes rearrange. 
Viruses can also cause cancer by transforming the infected cells by interfering with the 
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expression of regular proliferation and growth control. Typically the human tumour 
viruses carry and express e.g. human papillomavirus (HPV), Epstein Barr virus (EBV), 
Kaposi’s sarcoma herpesvirus (KSHV)) with it or activate cellular genes through 
integration into the host DNA next to proto-oncogene leading to its activation e.g. 
hepatitis B virus (HBV)). Infection by these viruses can increase the chance of a normal 
cell to transform into a cancer cell but does not necessarily lead to the development of 
the disease. Examples of cancers caused by these viruses are cervical carnioma by 
HPV, Burkitt’s lymphoma (EBV), human herpesvirus 8 (HHV-8) causing Kaposi’s 
sarcoma, hepatitis B and C –viruses which cause liver cancer by HBV  (Solunetti, 2015). 
 
Although carcinogens can be accounted for some of the most common mutations in 
cancers, mutations occur spontaneously even with no known mutagens present. Rate of 
spontaneous gene mutations per gene per cell division is around 10-6 (Alberts, et al., 
2015), which means that in a lifetime single gene might undergo about 1010 separate 
mutations. Some of these mutations occurs in genes that regulate division and growth, 
causing the cells to defy the normal limitations of cell proliferation. However, not all of 
these cells survive the mutations, and apoptosis eradicates the mutated cell clones. DNA 
repairing machinery also plays a vital role in the minimizing the harm mutations cause to 
DNA. Several percentages of genomes coding capacity is reserved for DNA repair 
functions, which is essential for the preservation of genome integrity. (Alberts, et al., 
2015). Less than 0.02% of tens of thousands of daily mutations generated by heat, 
metabolic accidents, radiation or substances in environment accumulate as permanent 
mutations in the DNA sequence. Variations in the genetic information that do not make 
any difference to the way the message is read or to the protein that is produced by the 
cell are quite common (Alberts, et al., 2015). 
 
Proto-oncogene is an initially normal cellular gene that can transform into an oncogene 
at least two different ways: i) through a point mutation such as replacement of one base 
pair to an alternative one, ii) through larger genomic rearrangement such as 
translocation, duplication, inversion or deletion of DNA from one chromosome to another 
(Alberts, et al., 2015). Proto-oncogene encoded proteins act like accelerators of growth 
and in protein translation they are participating in many processes like cell cycle 
progression, apoptosis and differentiation (Chi, 2012) (Chial, 2008). An example of a 
proto-oncogene is a transcriptional regulator MYC, which regulates approximately 10-
15% of human genes. MYC expression is documented to be elevated in approximately 
70% of human cancers (Gurell, et al., 2008).  
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In addition to activation of oncogenes, cancer initiation depends on inactivation of genes 
that restrict growth and proliferation. These genes produce cellular proteins that regulate 
cell cycle progression and will stop cell cycle if the DNA is damaged, hormone receptors 
that restrict the cell from dividing, proteins that promote apoptosis, and enzymes that 
contribute to DNA repair. For example, p53 is a gene that takes regulates apoptosis and 
takes part in regulation of cell cycle by stopping the cell cycle to the G1 phase if the DNA 
is damaged which means that DNA replication in the S phase will not start (Figure 2).  
 
 
Figure 2. The division cycle of most eukaryotic cells is divided into four discrete phases: M, G1, 
S, and G2. M phase (mitosis) is usually followed by cytokinesis. S phase is the period during 
which DNA replication occurs. The cell grows throughout the interphase, which includes G1, 
S, and G2. (Alberts, et al., 2015) 
 
3.2 Melanoma overview 
 
It is estimated that globally there is over 200,000 new melanoma cases per year, with an 
estimation of 46,000 deaths per year (Erdman, et al., 2012). In Finland, nearly 1200  new 
cases of melanoma are found diagnosed per year (Suomen syöpärekisteri, 2015). That 
is 4.1% of all cancers recorded in Finland. The combined 5-year survival rates of all 
melanoma are 84% for males and 89% for females in Finland (Engholm, et al., 2014). 
Mortality rates around continents range from 1.8 deaths in Africa to 11.2 in Europe per 
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100,000 where the difference can be explained mostly by ethnical backgrounds (Ferlay, 
et al., 2014). 
 
  
 
Figure 3. The TNM (Tumour Node Metastasis) categories for the seventh edition of the American 
Joint Comitee of Cancer Staging and Clasification Manual (3A), Survival curves from the 
American Joint Committee on Cancer Melanoma Staging Database comparing the different 
T categories and (3B), the different N categories (3C). 
 
 
Although the melanoma survival rates are good in cases where the tumor has not spread, 
however once the melanoma has spread to the lymph nodes (Stage III or N1-3), the 5-
year survival rate drops to 40% - 70% depending on the N category as seen on Figure 
5. Despite of recent progresses in the treatment regimens targeted towards the main 
driver mutations of melanoma, most notably the BRAF mutant which is found in 
approximately 40 % of cutaneous melanomas (Davies et al., 2002, Curtin et al., 2005) 
(Kim, et al., 2015), the treatments are hardly ever curative in patients with the M-category 
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distant metastatic disease (stage IV) where survival rate drops to 15% - 20 % (Larkin et 
al., 2014). 
 
 
3.3 Melanoma progression 
 
Thickness of the primary tumour is the best characterized property when predicting the 
melanoma metastasis (Balch et al., 2009). The most significant event in the melanoma 
primary tumour progression is the shift from a radial growth phase, where the melanoma 
cells are growing along the epidermis, to a vertical growth phase, which is characterized 
by tumour cell invasion into the deeper layers of the skin (Figure 3) (Chin, 2003). 
Adhesive properties and increased stimulation of the tissue degrading proteases are 
shown to increase tumour progression and increases invasion of cancer cells (Villanueva 
and Herlyn, 2008, Moro et al., 2014). Moreover, the change from radial to vertical growth 
phase is related to an increase of vascular endothelial growth factor (VEGF) quantity 
leading to vascularization and capillary leakage are both predictive factors of the 
malignant melanoma metastatic development as well (Figure 5) (Braeuer et al., 2011).  
 
 
Figure 4. Primary malignant melanoma progression. If the melanoma tumour is detected in radial-
growth phase, it can usually be removed quite easily with surgical actions. In vertical-growth 
phase tumour gains the potential to invade tissue and surgical removal becomes much harder 
(CancerLink - Neoplastic Diseases Reviews, 2010). 
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Figure 5. Invasion staging of melanoma (PDQ Melanoma Treatment–for health professionals , 
2015). 
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The prognosis of melanoma gets worse as with the progression of stages and 
time(Figure 4 and Figure 5A). From stage III onwards the melanoma has been linked to 
poor survival in the time of five years (Balch, et al., 2009). During recent years it has 
become increasingly clear that the lymphatic endothelial cells (LECs) might interact with 
their surrounding cells and tissues and regulating both physical and pathological 
processes (Emmett, et al., 2011) (Nagano, et al., 2012) (Pekkonen, 2015). In this study, 
we set to investigate if the LEC – melanoma cell interactions are directly contributing to 
the metastatic phenotype of melanoma, and would thus facilitate the tumour progression. 
To this end, Prof. Päivi Ojala’s laboratory developed several LEC-melanoma co-culturing 
systems, from which RNA-seq analysis was performed to decipher global gene 
expression changes in the melanoma cells co-cultured with LECs. 
 
 
 
4 Next generation sequencing  
 
4.1 RNA-sequencing  
 
In May 2008, astonishingly within three weeks, Science, Cell, Nature and Nature 
Methods published online the five world first articles introducing the new novel technique 
that has been upsetting microarray industry since then. The method now recognized as 
RNA-sequencing provides higher resolution picture of transcription than what was the 
standard before. The main goal of experiments using RNA-sequencing is to assay the 
transcriptome and RNA isoforms to accurately quantify gene expression levels. RNA-
seq technology does not require species- or transcript-specific probes like microarrays 
do. The technology behind RNA-seq relies heavily on deep sequencing which means 
that every genomic region in the samples is sequenced hundreds or thousands of times 
to make sure that the possible errors while sequencing are singled out (Meyerson, et al., 
2010) (Illumina, 2015).   A population of RNA is converted to a library of cDNA fragments 
with nucleotide adaptors, commonly poly-T tails, connected to one or both ends of the 
cDNA fragment (single or paired end sequencing). Each polynucleotide molecule is then 
sequenced in a high-throughput manner, to obtain short sequences. Reads are typically 
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30-400 base pairs long, depending on the sequencing technology used (Illumina, 2015). 
Various sequencing platforms are supported including Illumina, Life Sciences, Roche 
454 and Applied Biosystems. After sequencing the resulting reads are assembled de 
novo without the genomic sequence or aligned to a reference genome or reference 
transcripts to produce a genome scale transcription map. 
 
Over the years, RNA-seq has been gradually overtaking microarrays to become the tool 
of choice for genome wide analysis of the transcriptome (Wang, et al., 2009). It can 
detect novel transcripts, gene fusions, single nucleotide variants, small insertions and 
deletions, and other previously unknown nucleotide changes that arrays cannot detect, 
which makes it extremely versatile for studying complex transcriptomes (Wang, et al., 
2009). 
 
 
4.2 Illumina sequencing technology 
 
Sequencing technology used for the RNA-seq data in this thesis was from Illumina. 
Illumina sequencing relies on standard dideoxy method (Lasken & McLean, 2014) with 
few innovations incorporated (Alberts, et al., 2015). Assay in which the sample cDNA 
fragments are immobilized receives a DNA polymerase cocktail with different 
fluorescently labelled nucleotides A, T, G and C. Different fluorescent molecules are 
attached to each four nucleobases that thus emit four different wavelengths of light for 
nucleobase identification purposes. Bases also carry a chemical group that is attached 
to the base (3’-end block), while inhibiting the elongation by DNA polymerase. The cycles 
of sequencing are regulated by this block so fluorescent signal can be read correctly. 
Only complementary nucleotides in the template binds to the clusters and the rest is 
washed away alongside with blocking group and fluorescent label (Figure 6). Every time 
the process repeats high-resolution camera takes image or continuous video of which 
four nucleotides was added to the chain of each cluster.  
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Figure 6. Each cycle completed by RNA-sequencing takes approximately one hour in which 
modified nucleotide incorporation, image acquisition and removal of the 3’block and 
fluorescent group happens billions of times simultaneously (Alberts, et al., 2015) (Illumina, 
2015).  
 
 
 
Illumina platform makes it possible to sequence billions of reactions at the same time. 
Each individual sequence read is approximately 200 nucleotides long, which is shorter 
than with the other sequencing instruments but the vast amount of massive parallel 
sequencing is able to produce several human genomes worth of a replica sequence 
during 24h meaning additional increase in the sequencing depth (Illumina, 2015).  
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PRACTICAL PART 
 
5 Materials and methods 
 
5.1 RNA sequencing (RNA-seq) 
 
RNA extraction for the RNA sequencing analysis was done from three independent 
experiments with a TRI reagent (Sigma) protocol supplemented with phenol-chloroform 
precipitation step or with NucleoSpin RNA II kit (Macherey Nagel) (Pekkonen, 2015). The 
extracted RNA concentrations were measured with NanoDrop, and Bioanalyzer (Agilent 
Technologies) analysis was performed to check the RNA quality. RNA sequencing was 
performed with NextSeq500 sequencer (Illumina) as quadruplicates following standard 
protocol. The sequence data was aligned to human GRCh38.76 reference genome with 
using Chipster’s Tophat2 aligment and the differentially expressed genes were obtained 
by using DESeq2 Bioconductor package. Genes with adjusted p-values less than 0.05 
were considered significant. The cutoff for the FoldChange was set from 1 to -1 for further 
studies. Individual gene/transcript expressions are shown as counts.  
 
 
5.2 Chipster 
 
Chipster is a multipurpose bioinformatics data analysis platform with interactive 
visualizations and possibility for pipeline workflows developed by CSC - IT Center for 
Science Ltd (Figure 7). It is released under General Public Licence version 3 (GPLv3) 
which means it is free to use and share for any purpose. Chipster has an extensive 
collection of analysis tools for next generation sequencing (NGS), microarray and 
proteomics data (Chipster, 2015). The NGS options cover quality control analysis from 
raw sequence data to alignment, differential expression analysis and extensive 
applications such as pathway analysis. In this thesis Chipster was used for quality 
control, alignment and reading the count matrix which can be used for downstream 
analysis. Chipster client software uses Java Web Start that connects to CSC’s servers 
where the actual computing is done. The server runs variety of programs which can be 
selected and executed from the users Java interface. Functions used in this thesis are 
FastQC, Tophat2, HTSeq and Define NGS Experiment utility (Kallio, et al., 2011).  
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Figure 7. The Chipster program focuses on graphical interface and the representation of 
functions is informal therefore it is quite easy to start using (Kallio, et al., 2011). 
 
5.3 FastQC and PRINSEQ 
 
FastQC produces several quality control plots which are important when evaluating the 
condition of raw sequence files before doing any further analysis (Figure 8). If the quality 
is not optimal, trimming and filtering of sequence reads must be done, otherwise the 
downstream analysis will not provide statistically relevant results (Kallio, et al., 2011). 
The FastQC in this thesis was used as in Chipster. PRINSEQ can be used for quality 
checks as well, but here we used it to trim the ends of the poly N or A/T tails which were 
used in the sequencing. 
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Figure 8. FastQC standalone program example. The quality control is essential in discovering 
how succesfull the RNA-seq data run was (Anders, et al., 2015). 
 
 
 
5.4 Tophat2 and Bowtie2 
 
Tophat2 is a fast splice junction mapper for RNA-Seq reads. It aligns RNA-Seq reads to 
genomes using the short read aligner Bowtie2, and then analyses the mapping results 
to identify splice junctions between exons. Bowtie2 is fast and memory-efficient tools for 
aligning sequencing reads to long known reference sequences. It is relatively good at 
aligning either in the range of 50 – 100 or up to thousands of sequence character worth 
of reads and excels in aligning to long genomes.  By default, Tophat 2 performs end-to-
end read alignment which can be also called by the name “untrimmed” or “unclipped” 
alignment. Basically, it compares reference genome characters to read characters and 
calculates alignment scores.  
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The following example of how the Tophat 2 alignment scores are calculated is described 
in the manual at http://bowtie-bio.sourceforge.net/bowtie2/manual.shtml and it clarifies 
the alignment process.  
 
Read:      GACTGGGCGATCTCGACTTCG 
Reference: GACTGCGATCTCGACATCG 
 
Alignment: 
  Read:      GACTGGGCGATCTCGACTTCG 
             |||||  |||||||||| ||| 
  Reference: GACTG--CGATCTCGACATCG 
 
A mismatched base at a high-quality position in the read receives a 
penalty of -6 by default. A length-2 read gap receives a penalty of -
11 by default (-5 for the gap open, -3 for the first extension, -3 for 
the second extension). Thus, in end-to-end alignment mode, if the read 
is 50 bp long and it matches the reference exactly except for one 
mismatch at a high-quality position and one length-2 read gap, then 
the overall score is -(6 + 11) = -17.  
The best possible alignment score in end-to-end mode is 0, which 
happens when there are no differences between the read and the 
reference. (http://bowtie-bio.sourceforge.net/) 
 
5.5 HTSeq for counting reads 
 
A very typical part when using the HTSeq library is to a give it a list of genomic features 
(such as genes or exons) and it calculates how many sequencing reads overlap each of 
the feature (Anders, et al., 2015). These reads are transcribed to counts and used for 
main analysis measurement in downstream analyses with methods like DESeq2 (Love, 
et al., 2014), GAGE (Luo, et al., 2009) and Pathview (Luo & Brouwer, 2013). The script 
htseq-count is designed for differential expression analysis, only reads mapping 
unmistakeably to a single gene are counted, while reads aligned to multiple locations or 
overlapping with more than one gene are discarded. This sort of mapping is desirable, 
as one of two genes which have some similarity between sequences are differentially 
expressed. A read that maps to both genes similarly should be discarded, because if it 
were counted for both genes, the additional reads from the differentially expressed gene 
could also cause the other gene to be accidentally called differentially expressed (Nature 
America, Inc., 2013) (Anders, et al., 2015). 
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5.6 The R Project 
 
R is a language and environment for statistical computing and graphics. R provides a 
wide variety of statistical (linear and nonlinear modelling, classical statistical tests, time-
series analysis, classification, clustering etc.) and graphical techniques, and is highly 
extensible (Figure 9) (R Core Team, 2015). The platform of R can be extended through 
community created packages as the functions allow for specialized statistical techniques 
or graphical devices. This thesis used R project Bioconductor which is a software 
developed for computational biology and bioinformatics. In total there is over 6600 
additional packages as of May 2015 which are available at the Comprehensive R Archive 
Network (CRAN), Bioconductor and other repositories. The main packages used in this 
thesis through Bioconductor were: DESeq2, GAGE, pathview, ggplot2. 
 
 
 
Figure 9. R code can be highly specified to meet the needs of the changing are of bioinformatics 
and statistics (R Core Team, 2015). 
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5.7 DESeq2 
 
An essential task in analysing the high-throughput sequencing data such as RNA-seq 
count data is to find indication of systematic change across experimental treatment 
conditions (Lesk, 2014). DESeq2, which was used here as a bioconductor package, uses 
shrinkage estimation of dispersion and fold changes to analyse differential expression of 
count data (Zhang, et al., 2014). Analyse method focuses more on quantitative strength 
rather than mere existence of differential expression (Love, et al., 2014). The null 
hypothesis in these kinds of tests is commonly the same: fold change of gene expression 
between untreated and treated samples is precisely zero. This means that if the null 
hypothesis is true, we will not find genes significantly affected by the treatment. Statistical 
p-value represents the probability for the null hypothesis.  The aim of the analysis is to 
acquire list of genes that pass several test criteria. These genes are called statistically 
significantly. The most interesting genes in this list are significantly expressed, usually 
meaning under -2 or over 2 Fold Change (FC) ratio, but the FC bounds are situational 
case by case.  Although gene might not change its expression at all it still might be 
significant to know that the gene does not change its behaviour according to treatment. 
(Love, et al., 2014) 
 
DESeq2 operates by using shrinkage estimators for dispersion and test for differential 
expression by using model based on negative binominal distribution which is a discrete 
probability (Love, et al., 2014). The shrinkage of fold changes per sample basis is 
calculated by the regularized-logarithm transformation (rlog) or by variance stabilized 
transformation (VST). Both rlog and VST produce data on the log2 scale which has been 
normalized with respect to RNA-seq library size (Love, et al., 2014). For genes with 
higher counts, the rlog or VST transformation does not differ much from a common log2 
transformation, however genes with lower counts, the values are shrunken towards the 
genes average across all samples which improves sensitivity of the method (Zhang, et 
al., 2014).  
 
  
5.8 KEGG and GO ontologies 
 
One of the major challenges in a current and future genomic era is to build a complete 
computer model of the cell or a multi cellular organism, in which we could be able to 
predict higher complex cellular processes and behaviour from the genomic information. 
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KEGG (Kyoto Encyclopedia of Genes and Genomes) tries to answer this problem by 
integrating the top current understanding on molecular high-level functions such as 
pathways, genes and proteins and biochemical  compounds and reactions that 
happen in the cells (Kaneisha & Goto, 2000). Basically KEGG is a collection of manually 
drawn pathway maps from literature. GO (Gene Ontology Consortium) on the other hand 
focuses more on describing genes and gene products and their association with 
biological processes, molecular functions and cellular components. GO aims to address 
problems that KEGGs manual curation has by being responsive to automatic annotation 
possibilities. This has led to almost 99% of the GO data being curated automatically 
(Plessis, et al., 2011). In the thesis we use these two knowledge based systems as a 
platform to visualize the enrichment of our RNA-sequencing experiment genes.  
 
 
5.9 Generally applicable gene enrichment analysis (GAGE) 
 
If a researcher does not want to study only down or up regulation of gene expression, 
GAGE is a simple and well published method for performing a gene set enrichment 
analysis(Luo, et al., 2009). It gives insight to wider scale changes in a cell culture. In this 
study GAGE is used as  R package and enrichment analysis with both GO and KEGG 
databases is performed at chapter 7.3.  
 
5.10 Pathview 
 
The Pathview R package is a tool set for pathway based data integration and 
visualization (Luo & Brouwer, 2013). It maps and renders user data on relevant pathway 
graphs. User needs is to supply their gene or compound data and specify the target 
pathway and Pathview automatically downloads the pathway graph data, parses the data 
file, maps user data to the pathway, and renders pathway graph with the mapped data. 
Although built as a stand-alone program, Pathview seamlessly integrates with pathway 
(and functional) analysis tools for a large-scale and fully automated analysis pipeline. 
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6 Quality control of data and alignment 
 
6.1 Experimental design 
 
The melanoma cell lines used for the RNA-sequencing were WM852 and Bowes. 
WM852 is isolated from a melanoma skin metastasis and exhibits more aggressive 
features whereas Bowes is isolated from superficially spreading melanoma and is more 
indolent.  The experiment setup (Figure 10.) for the WM852 and Bowes melanoma cell 
lines were the same. Both cancer cell lines had 3 samples with consisting of only cancer 
cells, and 3 samples with of LEC primed cancer cells. WM852 was cultured for 48h and 
Bowes for 24h. Both cell lines were treated with the same procedure  and the melanoma 
cells were separated from LECs and harvested. Cells were pelleted and frozen to -80°C 
to wait for mRNA isolation.  
 
 
Figure 10. Overview of experimental setup for cell line based events. All cells were pelleted 
and also LECs could be subjected to RNA-seq as for later date if findings are interesting. 
 
 
Cancer cells were subjected to RNA-isolation with NucleoSpin RNA II kit (Macherey 
Nagel) or with Trizol isolation protocol (Sigma) supplemented with acid phenol-
chloroform precipitation step. The integrity of the RNA was analyzed with Bioanalyzer 
and consentrations were measured with  Nanodrop (Thermo Fisher Scientific) and the 
nanodrop results can be found in Table 1. 
 
=   Melanoma cancer cell                         = Melanoma cell RNA 
 
= Lymphatic endothelial cell                     = Lymphatic endothelial cell RNA 
 
       Cell culture                     Cell harvest           mRNA isolation                                RNA-sequencing 
    Cell culture                      Cell harvest and separation         mRNA isolation                             RNA-sequencing 
RNA-sequence 
data analysis 
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Table 1. Experimental RNA extracting sheets of the two cell lines WM852 and Bowes. Pellet 
date tells the date when the culturing was done and the pellet was formed after the 
harvesting and separation of the cells.  
Sample  Description RNA 
isolation 
Pellet date RNA 
c(ng/ul) 
260/
280 
260/
230 
Kit 
1 
WM852 1.exp 12.11.2014 7.11.2014 266,8 2,12 1,74 MN 
2 
LEC primed WM852 1.exp 12.11.2014 7.11.2014 235,27 2,1 2,05 MN 
3 
WM852 2.exp 28.11.2014 27.11.2014 133,18 1,83 0,77 Sigma 
4 
LEC primed WM852 2.exp 28.11.2014 27.11.2014 101,71 1,79 0,63 Sigma 
5 
WM852 3.exp 2.12.2014 27.11.2014 172,8 1,75 0,55 Sigma 
6 
LEC primed WM852 3.exp 2.12.2014 27.11.2014 121,68 1,75 0,41 Sigma 
 
 
Sample  Description RNA 
isolation 
Pellet date RNA 
c(ng/ul) 
260/
280 
260/
230 
Kit 
1 
Bowes 1.exp 16.2.2015 22.1.2015 179,75 1,88 1,08 Sigma 
2 
LEC primed Bowes 1.exp 16.2.2015 22.1.2015 221,84 1,86 0,83 Sigma 
3 
Bowes 2.exp 16.2.2015 30.1.2015 126,34 1,86 1,38 Sigma 
4 
LEC primed Bowes 2.exp 16.2.2015 30.1.2015 136,68 1,78 0,55 Sigma 
5 
Bowes 3.exp 16.2.2015 3.2.2015 87,63 1,74 0,48 Sigma 
6 
LEC primed Bowes 3.exp 16.2.2015 3.2.2015 124,95 1,77 0,52 Sigma 
 
 
Extracted melanoma mRNA samples were sent to DNA Sequencing and Genomic’s 
laboratory at Institute of Biotechnology where it was sequenced in January 2015 
(WM852) and in March 2015 (Bowes). 
 
Both sequencing runs were performed with single end protocol using Illumina NextSeq 
500 sequencer. RNA sequencing raw results are in a format .fastq that is default format 
for most of the sequencing programs. In total we had six biological samples derived from 
three cancer cell only cultures and three LEC primed cancer cell cultures. Each sample 
was divided to four technical replicates for the RNA-sequencing step. In the data analysis 
phase we had 24 samples (.fastq files) for further studies. In this project we used data 
analysis platform Chipster to perform a quality check, aligment and count extraction for 
both of the different data sets WM852 and Bowes. Both experiments are analysed 
separately  
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6.2 FastQC 
 
The FastQC analysis was done to each of the 24 sample files we got from the sequencing 
laboratory. Quality of the reads were evaluated by Phred quality scores. For example, 
Phred 30 score means to tell us that 99,9% of the reads are accurately sequenced (Table 
2).   
 
Table 2. Phred Quality Score is linked logarithmically to error probabilities (Ewing & Green, 
1998). 
Phred Quality Score Probability of incorrect base call Base call accuracy 
10 1 in 10 90% 
20 1 in 100 99% 
30 1 in 1000 99.9% 
40 1 in 10,000 99.99% 
 
 
Figure 11. FastQC for the cancer cell lines. The two quality examples in the top row are done 
with different encoding Illumina 1.5 encoding versus our samples which were done with 
Sanger / Illumina 1.9 encoding so the two are not possibly likewise comprisable.   In the Y-
axis is phred33 quality code, in the X-axis base pair position in the read. Green area means 
good, yellow area acceptable and red is bad quality.  
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In our experiment, the quality check of the sequencing results looked good, as all 24 
samples in both experiments showed Phred scores over 26 (see examples, Figure 11 
bottom row), meaning our base call accuracy was calculated accordingly equation (1), 
where Q is phred score, P is base calling error probality. Our base call accuracy minimum 
was 99,7488%.  
 
(1)                       𝑄 = −10 𝑙𝑜𝑔10𝑃 
 
As the sequencing quality was particularly good, no trimming or filtering of the reads was 
necessary except for the poly A/T tails which was done with PRINSEQ (Figure 11). If 
sequencing quality is poor, i.e. yellow bars in the Figure 11 drop to red area, the trimming 
and filtering is necessary for accurate downstream analysis.  
 
 
6.3 Tophat 2 alignment 
 
From the conducted steps, the alignment step needs the most of raw computational 
power. To accelerate this process, Chipster is built so that it does the calculations in a 
server at the CSC and not from the computer it is used from. However, Chipster can only 
queue 10 commands, so the commands had to be added to the queue after the first few 
queues were done and the alignment process itself took approximately 72 hours. The 
genome used for the alignment was Homo sapiens GRCh38.76.  
 
The alignment was conducted with parameters described under: 
 
Dataset name: tophat.bam 
Created with operation: Alignment / TopHat2 for single end reads 
Parameter Genome: Homo_sapiens.GRCh38 
Parameter Use annotation GTF: yes 
Parameter When GTF file is used, ignore novel junctions: no 
Parameter Base quality encoding used: Sanger - Phred+33 
Parameter How many hits is a read allowed to have: 20 
Parameter Number of mismatches allowed in final alignment: 2 
Parameter Minimum anchor length: 8 
Parameter Maximum number of mismatches allowed in the anchor: 0 
Parameter Minimum intron length: 70 
Parameter Maximum intron length: 500000 
Parameter Library type: fr-unstranded 
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6.4 HTSeq count reading 
 
Next the count data was obtained by using Chipster function HTSeq (Figure 12). For 
each gene, it is counted separately how many aligned reads from the genome overlap 
its exons. The count table generated by HTSeq is in an easily accessible .csv format and 
can be opened with most of the text or table editors.  
 
 
Figure 12. The count table of WM852 opened in Microsoft Excel 2013 with color coded 
colums for clarity. Red is the Ensembl gene ID, green colums represent the cancer only 
samples and blue ones the LEC primed samples. Column name S1_R1 can be interpreted 
as Sample1_Replicate1. 
 
 
The counts for each gene were used for differential expression in chapter 7.1. 
Approximately 62 000 gene IDs were retrieved in the raw count data file. One third of 
them were protein coding genes and the rest two thirds is categorised as noncoding DNA 
sequences. The noncoding sequence include genes that are automatically annotated as 
well as pseudogenes, introns, rRNA, tRNA, microRNA, and telomeres. 
 
Table 3. Top hits in WM852 by abundance for reference where the counts are sorted by 
descending row count average. Ensembl ID and Gene Symbol is just an alternative 
representation for each other and the description is pulled from HUGO.  
 
 
 
Ensembl ID Gene  Symbol Description 
Average 
counts per 
sample 
W ENSG00000210082 MT-RNR2 mitochondrially encoded 16S RNA  1182006 
M ENSG00000202198 RN7SK RNA, 7SK small nuclear  782998 
8 ENSG00000211459 MT-RNR1 mitochondrially encoded 12S RNA  126018 
5 ENSG00000274012 RN7SL2 RNA, 7SL, cytoplasmic 2  86365 
2 ENSG00000111640 GAPDH glyceraldehyde-3-phosphate dehydrogenase 30640 
 
Ensembl ID S1_R1 S1_R2 S1_R3 S1_R4 S2_R1 S2_R2 S2_R3 S2_R4 S3_R1 S3_R2 S3_R3 S3_R4 S4_R1 S4_R2 S4_R3 S4_R4 S5_R1 S5_R2 S5_R3 S5_R4 S6_R1 S6_R2 S6_R3 S6_R4
ENSG00000000003 133 111 121 134 198 207 221 197 202 218 208 211 463 407 474 459 385 347 391 367 404 374 386 380
ENSG00000000005 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
ENSG00000000419 268 240 270 210 478 477 457 418 474 512 480 483 1377 1303 1358 1354 993 918 950 943 875 884 947 828
ENSG00000000457 31 28 29 26 23 23 26 25 19 19 27 19 60 56 69 47 43 47 51 35 33 36 40 34
ENSG00000000460 141 128 147 126 166 144 176 163 81 73 90 90 277 299 298 288 205 189 213 224 199 210 251 228
ENSG00000000938 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0
ENSG00000000971 0 0 0 0 0 0 1 1 0 0 0 0 0 2 0 0 0 0 0 0 2 1 1 3
ENSG00000001036 166 150 181 166 206 197 176 207 124 110 141 130 297 277 326 317 263 233 268 278 298 291 335 310
ENSG00000001084 3 2 5 5 16 13 16 19 1 2 3 4 20 30 30 28 10 8 6 8 34 30 38 26
ENSG00000001167 107 127 133 102 118 123 118 130 107 119 113 114 281 241 288 264 214 201 233 235 213 177 195 178
ENSG00000001460 58 60 56 61 64 51 65 52 15 22 21 24 78 63 80 85 77 71 62 64 54 63 79 66
ENSG00000001461 714 697 741 755 497 463 543 536 293 328 335 351 711 623 633 689 734 767 848 786 715 712 746 753
ENSG00000001497 649 592 661 623 479 490 521 528 463 436 467 479 865 804 977 882 845 798 879 835 887 935 1030 1008
ENSG00000001561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
ENSG00000001617 2 6 8 7 19 15 21 18 3 1 4 2 13 14 16 16 1 3 3 3 37 46 45 47
ENSG00000001626 2 1 0 2 2 4 4 1 0 0 0 0 0 1 3 2 0 0 0 2 0 0 2 0
26 
 
 
Ensembl ID Gene  Symbol Description 
Average 
counts per 
sample 
B ENSG00000210082 MT-RNR2 mitochondrially encoded 16S RNA  2165487 
O ENSG00000202198 RN7SK RNA, 7SK small nuclear  385973 
W ENSG00000211459 MT-RNR1 mitochondrially encoded 12S RNA  177427 
E ENSG00000198938 MT-CO3 mitochondrially encoded cytochrome c oxidase III 43054 
S ENSG00000198804 MT-CO1 mitochondrially encoded cytochrome c oxidase I 37085 
 
 
Mitochondrial and ribosomal RNA is the most abundant mRNA in the samples.  The top 
genes by abundance (Table 3) are usually household genes both non-coding and coding, 
that are required to maintain the cell viable and operational and are therefore produced 
in great numbers. MT-RNR 1 and MT-RNR 2 are genes that encode rRNA, RN7SK 
controls transcription and RN7SL2 is a part of signal recognition particle. GAPDH works 
as catalysing enzyme in the sixth step of glycolysis breaking down glucose for energy 
and carbon molecules for the cell. Cytochrome oxidases MT-CO1 and MT-CO2 are part 
of the last enzymes in the electron transport chain (Cunningham, et al., 2015).  
 
6.5 Quality control of count data 
 
Quality of the count data needs to be analysed within R where the processing of the 
differential expression analysis is done. Relationships between samples can be 
observed with different statistical methods including principal component analysis 
(Figure 14). Most common method is to normalise the count data for the downstream 
analysis. The normalisation method (Figure 13) used for the Deseq2 quality analysis can 
be regularized logarithmic transformation (RLOG) or variance stabilised transformation 
(VST). The normalisation used in this thesis was VST. Basic rule for the transformation 
is to pick a one with visually straight red line (Figure 13) or just choose between either 
RLOG or VST (Love, et al., 2015) (Icay, 2015). 
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Figure 13. Effect of different transformations visualised. The per-gene standard deviation 
taken across samples, against the rank of the mean (log2(n+1).  Variance stabilised 
transformation takes genes with small count numbers better in to account. Y-axis presents 
standard deviation and x-axis the gene rank sorted by counts in ascending order. 
 
 
 
Figure 14. Principal component analysis of the top 500 most variance gene rows from count 
data of WM852 and Bowes after VST. Samples are divided into Principal component 1 and 
Principal component 2 according to their variance. Accuracy of the four replicates in each 
samples is high. The degree of distribution is clear because the sample conditions, visualized 
by circles, do not overlap. 
 
 
Quality of the data and similarities between samples was good overall. In Figure 14, 
some distparity between WM852 samples one and two can be seen. These samples 
  
LEC primed WM825    
                            Bowes  
 
 
 
 
 
 
 
 
WM852        LEC primed Bowes 
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represent the first pair of the whole experimental set and were isolated with different RNA 
isolation kit (Table 1). WM852 samples are clustered well in  PC2 and slightly dived in 
PC1 because of the disparity of samples one and two. In Bowes sample 3 was distanced 
from it’s condition average in PC2, but remains clustered in PC1. Overall the technical 
replicate data was excellent, but the biological variance between the samples was quite 
high. Although the cell line grows and multiplies while the phenotype of the cell stays the 
same, gene expression levels might have significant variation and act differently 
depending on the situation. In conclusion, biological variance  has to be accounted as a 
major variable. 
 
The analysis of significant gene expressions changes was done in R – Bioconductor 
package DESeq2, which calculates significant expression of genes from raw counts. 
Research group made a decision to filter out genes that had under one count in more 
than 12 samples before their count table inclusion to the DESeq2 analysis. The reason 
for the filtering is that low or zero count genes do not have same statistical power in the 
analysis because the variance difference. There might be also uncertain counts because 
of the read errors in both sequencing and alignment. DESeq2 automatically applies VST 
normalisation and fits the dispersion as seen in Figure 15 and explained at 5.7. 
 
 
 
Figure 15. Variance stabilized transformation effect shown in dispersion estimate plot. The 
gene-wise estimates (black), the fitted values (red), and the final maximum estimates used in 
testing (blue).  
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7 Results of RNA-seq data analysis 
 
7.1 Differential expression analysis 
 
In standard statistical analysis the different condition values are usually compared to one 
another. In this analysis the experimental conditions are untreated cancer cells (WM852 
or Bowes) versus treated cells (LEC Primed WM852 or Bowes).  
 
Easiest way to visualize the complex expression patterns that genes form is to draw a 
heatmap. In Figure 16, graphical representations of expression data matrix from 
DESeq2. With a quick look similarities and dissimilarities can be observed.  
 
 
  
Figure 16. Variance based heatmaps showing the top 500 most differentially variance genes 
in both populations. Dendrograms and clustering are done automatically and blue column 
colour represents LEC treated samples. Green and red represents how much the specific 
sample deviates from gene’s average across samples as green is to negative direction and 
red positive. 
 
In WM852 samples, samples one and two show clear distinctive difference compared to 
the other samples. However, the distribution of genes and variance looked well-defined 
in both data sets. 
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Genes that influence the output of the above heatmap and other figures are in the data 
matrix that is shown in Table 4. Each column has important data stored in them: 
 baseMean is the average of normalized factors 
 log2FC is the fold change between groups 
 FoldChange in base 10 format 
 lfcSE is standard error of log2fc 
 stat is wald test statistic 
 pvalue tells the probability value for true null hypothesis(no significant expression 
change)  
 padj is Benjamin-Hochberg adjusted p-value (False detection rate adjusted) 
 
 
Table 4. Example of six most and least expressed genes sorted by fold change from both 
populations. The gene names are coded in this version of the publication to not expose 
the results before the acceptance of the manuscript under preparation.  
 
 
 
In the RNA-sequencing analysis the amount of the data produced could be high, and the 
study could yield over thousand significantly expressed genes where singling out 
important genes could turn out to be problematic. There is really no good and simple 
solution to this but pathway and enrichment analysis could provide some hints of the 
biological importance and give good leads for further studies. Enrichment analysis is 
discussed in chapter 7.3. 
 
Ensembl ID baseMean log2FC FoldChange lfcSE stat pvalue padj
W Gene WM1 64.1 6.58 95.7 0.37 17.6 4.5E-69 1.2E-66
M Gene WM2 137.5 6.20 73.5 0.25 24.9 1.8E-136 2.3E-133
8 Gene WM3 15.1 5.40 42.2 0.39 13.9 5.5E-44 5.3E-42
5 Gene WM4 50.4 -2.60 -6.1 0.16 -15.9 9.3E-57 1.6E-54
2 Gene WM5 906.9 -2.72 -6.6 0.09 -30.4 3.4E-203 1.2E-199
Gene WM6 46.5 -2.80 -7.0 0.16 -17.2 2.2E-66 4.8E-64
Ensembl ID baseMean log2FC FoldChange lfcSE stat pvalue padj
B Gene BO1 200.5 5.04 32.9 0.14 36.7 3.9E-294 1.8E-290
O Gene BO2 538.9 4.51 22.7 0.15 30.7 5.1E-207 1.4E-203
W Gene BO3 467.5 4.45 21.8 0.15 29.0 3.0E-185 5.3E-182
E Gene BO4 118.7 -1.00 -2.0 0.18 -5.7 1.5E-08 4.0E-07
S Gene BO5 18.0 -1.04 -2.1 0.16 -6.6 2.9E-11 1.1E-09
Gene BO6 583.3 -1.08 -2.1 0.17 -6.3 3.6E-10 1.2E-08
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The overall direction of the whole population expression change can be also visualised 
with DESeq2 function plotMA (Figure 17), which is also a useful data diagnostics tool. 
 
 
Figure 17. MA plots of the results, showing genes mean expression in relation to its log2 fold 
change. On red colour, genes with significant expression changes with α<0.01. WM852 left, 
Bowes right. 
 
From the 62000 gene IDs that were part of the reference genome 19101 (WM852) and 
17240 (Bowes) passed the DESeq2 algorithm that also discards genes with low counts. 
WM852 had a total of 10008 significantly expressed genes, while Bowes had 3901. In 
the log2FC range of less than -1  or over 1, there were approximately 1130 significantly 
differentially expressed genes in the  LEC primed WM852 and 254 in the LEC primed 
Bowes populations. WM852 had been cultured for 48 hours which was twice as long as 
compared to Bowes. Culturing time difference could indicate the difference in the amount 
of genes differentially expressed in the two cell populations. Both populations had 
remarkably more up regulated than down regulated genes, which might be an indication 
of the experimental set-up favouring up regulation of gene expression.  
 
7.2 Methods of result verification 
 
When performing a large scale RNA-sequencing data analysis the validity is a probable 
concern (Zheng, et al., 2011). To this end, three validity threats were identified as 
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possible influencers of the result outcome.  First threat for the validity of the results is a 
mechanical experimental error for example in cell during the culturing phase or in 
measurement of correct nucleotides in RNA-sequencing. Second threat to validity is the 
error in analysis phase. Third validity threat lies in the interpretation of the results. 
 
As for the first threat, all cell-handling steps are well documented and repeatable and no 
minor or major mistakes were discovered. Second threat is more problematic to control 
as it exposes our data quality to major and possibly minor variations. Major variations 
are easier to filter out and eliminate as they are more blatant and obvious. Minor 
variations might contribute to approximately ± 0-10 % changes in the final values and 
results (Rapaport, et al., 2013). Minor errors might be well concealed because the effect 
might occur at the whole population level and nothing really stands out as a possible 
error source in the results. However, all the statistical analysis on the R platform can be 
easily repeated with the same end results. Furthermore all the analysis are done using 
standard adjustments. The publications describing the procedures offer complete 
workflows and manuals and are well cited and at the same time. The probability for the 
third validity threat depends on personal expertise, experience level and on the aspect 
that the subject is studied. To avoid the threats, all project steps were exposed to peer 
review and during the thesis work I also had the possibility to compare the differential 
expression results of WM852 to one previously performed by a graduate student (Icay, 
2015) in  System Biology group, Genome-Scale Biology Research Program Unit, Faculty 
of Medicine, University of Helsinki. The Systems Biology group completed their 
differential expression analysis with their RNA-sequencing data pipeline where Cufflinks 
is integrated as differential expression analyser (Icay, 2015). Cufflinks is a slightly 
different method but the results for the top genes should be the same nearly the same 
(Zhang, et al., 2014). From the same raw data we were able to obtain results that were 
nearly matching for the top genes. Figure 18 validates that our results did not suffer from 
major errors and the differential expression analysis was successful.   
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Figure 18.  Moving average of fold change difference to validate the result. First 2000 genes 
sorted by p-value. 
 
Most significant genes show approximately ~5% difference in fold change. The quality 
varies below the top genes and settles to around 10-15% of difference. However, 
DESeq2 is more sensitive as an analysis method than Cufflinks (Zhang, et al., 2014), 
and the two methods use different algorithms. Therefore, the difference between results 
can be partly explained with this. As the data obtained by DESeq2 turned out to yield 
similar results as Cufflinks, we chose to use the DESeq2 workflow to analyse RNA-
sequence data from the Bowes cells as described in 7.1. 
 
 
 
7.3 Enrichment and pathway analysis results  
 
Focusing on single genes might be interesting, but for larger scale changes in 
expression, enrichment result based on KEGG and GO annotations can be more 
informative (Kaneisha & Goto, 2000).  Here we used Generally Applicable Gene-set 
Enrichment (GAGE) method to perform a large variety of different enrichment group tests 
with different setups (Luo, et al., 2009). Because of the research in progress in this 
project, only selected outcome can be presented in this thesis. Figure 19 visualizes a 
heatmap produced by GAGE showing KEGG and GO enrichment groups. GAGE 
compares the groups with “paired” comparison where treated and untreated samples are 
of equal length and one-on-one paired according by the original experimental design 
(Luo, et al., 2009).  
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Figure 19. GAGE two directional test analysis, showing KEGG and GO annotation enrichment 
groups for Bowes cell line, where groups have statistical significance (α<1,0 x 10-21). Both 
populations show sets of interesting groups after lymphatic endothelial cell treatment. Brighter 
red colour means lower p-value. 
 
The primary results of the GAGE analysis are the enrichment scores that are outputted 
to tab limited text file and heatmaps (Figure 19) that are the visualization of the scores. 
Heatmaps reflect the degree to which a gene set is significantly expressed. GAGE 
calculates the scores by gene set differential expression test based on one-on-one 
comparison between samples from two experimental conditions untreated vs treated. 
The p-values shown in the Figure 19 are a result of a global p-value based meta-test on 
on the negative log sum of p-values from all one-on-one comparisons. Only gene sets 
with highest significance α<1,0 x 10-21 are presented in Figure 19.  
 
Enrichment results derived from GO show variety of groups that have been shown to be 
active in malignant cancer development (Penn, 2008). The blood vessel development is 
a process where aim is the formation and maturing of capillary and vascular vessels and 
in the end carrying blood to tissues. The vasculature development is an interconnected 
tubular multi-tissue structure that contains fluid that is actively transported around the 
organism. Angiogenesis refers to blood vessel formation when new vessels emerge from 
the proliferation of pre-existing blood vessels. Cell morphogenesis refers to a 
developmental process in which the size or shape of a cell is generated and organized. 
Mitotic cell cycle, the most common eukaryotic cell cycle (Figure 2) which canonically 
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comprises four successive phases called G1, S, G2, and M and includes replication of 
the genome and the subsequent segregation of chromosomes into daughter cells (The 
Gene Ontology Consortium, 2015). Cancerous cells might enrich these groups normally 
if compared to normal equivalent stromal cells. Here remarkably the treatment with LECs 
cause the cancer cells to significantly express groups shown in Figure 19 compared to 
same cancer cells.  
 
 
Figure 20. KEGG pathway called MAPK, which is an interesting signalling pathway in 
melanoma development. It is showed by directional test by GAGE, visualized by Pathview. 
Most detailed description of the graph can be viewed from 
http://www.genome.jp/kegg/document/help_pathway.html 
 
One of the pathways which genes were found enriched in the analysis of the LEC primed 
melanoma samples was the Mitogen-activated protein kinase (MAPK) pathway. It is 
composed of a group of proteins that deliver extracellular signals from the cell surface to 
the DNA in the nucleus (Figure 20). MAPK is highly conserved module involved in 
proliferation, differentiation and migration of cells. It usually functions as on-off switch for 
genes, while mutations to this pathway cause uncontrollable growth where tumours and 
cancer originate from. It is an important target for therapeutical treatments that aim at 
providing better outcomes for patients. The MAPK signalling pathway shows groups of 
targeted genes significantly expressed and most of them are upregulated. The single 
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target could be red, green or grey at the same time as differences in samples and 
replications is taken into account and visualized in Figure 20. Deregulation of the MAPK 
pathway in melanomas takes place frequently due to activating mutations in the B-RAF 
and RAS genes or other epigenetic or genetic alterations, leading to increased signaling 
activity promoting cell proliferation, invasion, angiogenesis, metastasis, distant migration 
and survival reference, thus representing a relevant pathway in melanoma (Chin, 2003) 
(Cargnello & Roux, 2015). 
 
8 Conclusions 
 
Sequencing data revelead extensive gene expression changes in both the LEC primed 
Bowes and WM852 melanoma cell lines when compared to Bowes and WM852 cell 
cultures alone. Bowes had fewer significantly differentially expressed genes, but the 
result could be due to different culturing time. However, both populations responded to 
the lymphatic endothelial cell treatment with in a similar manner. Enrichment results 
showed significant expression of pathways related to pathogenesis of cancer and tumour 
progression. These results indicate that the interaction and crosstalk with the LECs can 
contribute to the tumorigenic properties of melanoma cell lines WM852 and Bowes. 
 
The most interesting genes identified during in this RNA-seq analysis are currently being 
validated by qRT-PCR and cell-based functional assays in the laboratory of  Prof. Päivi 
Ojala. To protect the novelty of these findings for the manuscript in preparation, the 
identity of the genes and majority of additional findings cannot be presented in this thesis.  
 
Finally, it is vital to understand the mechanisms of malignant melanoma development 
and its ability to metastasize to find ways to improve the treatment modalities of this 
disease. The research done here will hopefully help not only to build a deeper 
understanding of the contribution of the stromal microenvironment to melanoma 
metastasis but also to develop more effective and specific ways to predict melanoma 
progression and to inhibit metastasis. 
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Appendix 1 
 
 
 
Chipster run parameters 
Step 1 
------ 
Dataset name: A006-co-culture-elute-3-exp-GAATTCGT-run20150316N_S6_L004_R1_001.fastq.gz 
Created with operation: Import / Import data 
  
Step 2 
------ 
Dataset name: trimmed.fastq.gz 
Created with operation: Preprocessing / Trim reads for several criteria with PRINSEQ 
Parameter Input file format: FASTQ 
Parameter Base quality encoding: Sanger 
Parameter Trim 5-prime end by quality: 0 
Parameter Trim 3-prime end by quality: 5 
Parameter Quality score calculation method: minimum quality value 
Parameter Quality score comparison condition: less than 
Parameter Window size for quality calculation: 1 
Parameter Step size used to move the quality window: 1 
Parameter Trim left A/T tails: 10 
Parameter Trim right A/T tails: 10 
Parameter Trim left poly-N tails: 10 
Parameter Trim right poly-N tails: 10 
Parameter Minimum length: 20 
Parameter Write a log file: yes 
  
Step 3 
------ 
Dataset name: tophat.bam 
Created with operation: Alignment / TopHat2 for single end reads 
Parameter Genome: Homo_sapiens.GRCh38 
Parameter Use annotation GTF: yes 
Parameter When GTF file is used, ignore novel junctions: no 
Parameter Base quality encoding used: Sanger - Phred+33 
Parameter How many hits is a read allowed to have: 20 
Parameter Number of mismatches allowed in final alignment: 2  
Parameter Minimum anchor length: 8 
Parameter Maximum number of mismatches allowed in the anchor: 0 
Parameter Minimum intron length: 70 
Parameter Maximum intron length: 500000 
Parameter Library type: fr-unstranded 
 
Step 4 
------ 
Dataset name: htseq-counts.tsv 
Created with operation: RNA-seq / Count aligned reads per genes with HTSeq 
Parameter Reference organism: Homo_sapiens.GRCh38.78 
Parameter Chromosome names in the BAM file look like: 1 
Parameter Does the BAM file contain paired-end data: no 
Parameter Was the data produced with a strand-specific protocol: no 
Parameter Mode to handle reads overlapping more than one feature: union 
Parameter Minimum alignment quality: 10 
Parameter Feature type to count: exon 
Parameter Feature ID to use: gene_id 
Parameter Add chromosomal coordinates to the count table: no 
Appendix 2 
 
 
 
R run parameters and script 
 
R script is located at: http://pastebin.com/f9Yrvibv  
